Denmark’s Novonesis to invest ₹6,660 crore in Maharashtra facility expansion
Danish biosolutions firm Novonesis is investing ₹6,660 crore to expand its production facility in Patalganga, Maharashtra. The project aims to meet global demand for enzymes and aligns with India's BioE3 policy for a sustainable bioeconomy.
Why it matters
This significant foreign direct investment signals growth in India's biotechnology sector and its integration into global supply chains.
Danish biosolutions company Novonesis has announced an investment of ₹6,660 crore (€600 million) to expand its facility at Patalganga in Maharashtra and establish an advanced enzyme production facility.
The expansion is aimed at increasing the company’s production capacity to meet growing global demand for biosolutions. The new facility, which is expected to be fully operational by 2030, will manufacture enzymes for a range of industries, including biofuels, household care, and food and beverages.
“The expansion strengthens our ability to support customers around the world and enables us to continue creating long-term value for our shareholders,” said Ester Baiget, President and CEO of Novonesis.
According to the company, the Patalganga facility will form part of Novonesis’ global production network and bring the company closer to customers in key emerging markets, including the Middle East, Africa, India and wider South Asia.
Get smarter about the news
Sign up free for a feed built around what you actually care about, Dive Deeper research on any story, and the full text of every article.
Create free accountAlready have an account? Sign in